Alpha 2.0
Login Register
» Authors » Alexander Kintu

Alexander Kintu

Explore the profile of Alexander Kintu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 13
Citations 348
Followers 0
Related Specialties
Infectious Diseases
Public Health
General Medicine
Top 10 Co-Authors
Moupali Das
Jared M Baeten
Yongwu Shao
Matthew M Coates
David Sando
Gene Bukhman
Christoph Carter
Christoph D Spinner
Goodarz Danaei
Stephane Verguet
Published In
J Acquir Immune Defic Syndr
J Int AIDS Soc
Glob Health Action
Lancet HIV
BMC Public Health
Affiliations
Soon will be listed here.
Recent Articles
1.
Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women
Bekker L, Das M, Abdool Karim Q, Ahmed K, Batting J, Brumskine W, et al.
N Engl J Med . 2024 Jul; 391(13):1179-1192. PMID: 39046157
Background: There are gaps in uptake of, adherence to, and persistence in the use of preexposure prophylaxis for human immunodeficiency virus (HIV) prevention among cisgender women. Methods: We conducted a...
2.
HIV-1 infection kinetics, drug resistance, and long-term safety of pre-exposure prophylaxis with emtricitabine plus tenofovir alafenamide (DISCOVER): week 144 open-label extension of a randomised, controlled, phase 3 trial
Wohl D, Spinner C, Flamm J, Hare C, Doblecki-Lewis S, Ruane P, et al.
Lancet HIV . 2024 Jul; 11(8):e508-e521. PMID: 39008999
Background: Data characterising the long-term use and safety of emtricitabine plus tenofovir disoproxil fumarate as daily oral pre-exposure prophylaxis (PrEP) are scarce and there are uncertainties regarding the value of...
3.
Gender Affirming Hormones Do Not Affect the Exposure and Efficacy of F/TDF or F/TAF for HIV Preexposure Prophylaxis: A Subgroup Analysis from the DISCOVER Trial
Cespedes M, Das M, Yager J, Prins M, Krznaric I, De Jong J, et al.
Transgend Health . 2024 Feb; 9(1):46-52. PMID: 38312459
Purpose: Transgender women are disproportionately affected by HIV and are underutilizing preexposure prophylaxis (PrEP). The lower uptake of PrEP by transgender women may be, in part, owing to the perception...
4.
Proximate and distal factors associated with the stall in the decline of adolescent pregnancy in Uganda
Mbabazi C, Kintu A, Asiimwe J, Ssekamatte J, Shah I, Canning D
BMC Public Health . 2021 Oct; 21(1):1875. PMID: 34663262
Background: Adolescent pregnancy in Uganda declined from 31% in 2000-01 to 25% in 2006 but thereafter stalled at 25% from 2006 to 2016. This paper investigates the factors associated with...
5.
Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial
Ogbuagu O, Ruane P, Podzamczer D, Salazar L, Henry K, Asmuth D, et al.
Lancet HIV . 2021 Jul; 8(7):e397-e407. PMID: 34197772
Background: In DISCOVER, a multinational, randomised controlled trial, emtricitabine and tenofovir alafenamide compared with emtricitabine and tenofovir disoproxil fumarate showed non-inferior efficacy for HIV prevention and improved bone mineral density...
6.
Burden of non-communicable diseases from infectious causes in 2017: a modelling study
Coates M, Kintu A, Gupta N, Wroe E, Adler A, Kwan G, et al.
Lancet Glob Health . 2020 Oct; 8(12):e1489-e1498. PMID: 33098769
Background: Non-communicable diseases (NCDs) cause a large burden of disease globally. Some infectious diseases cause an increased risk of developing specific NCDs. Although the NCD burden from some infectious causes...
7.
Noncommunicable Disease (NCD) strategic plans in low- and lower-middle income Sub-Saharan Africa: framing and policy response
Boudreaux C, Noble C, Coates M, Kelley J, Abanda M, Kintu A, et al.
Glob Health Action . 2020 Sep; 13(1):1805165. PMID: 32873212
Background: Global efforts to address NCDs focus primarily on 4-by-4 interventions - interventions to prevent and treat four groups of conditions affecting mainly older adults (some cardiovascular disease and cancers,...
8.
Integrating care for non-communicable diseases into routine HIV services: key considerations for policy design in sub-Saharan Africa
Kintu A, Sando D, Okello S, Mutungi G, Guwatudde D, Menzies N, et al.
J Int AIDS Soc . 2020 Jun; 23 Suppl 1:e25508. PMID: 32562370
Introduction: There is great interest for integrating care for non-communicable diseases (NCDs) into routine HIV services in sub-Saharan Africa (SSA) due to the steady rise of the number of people...
9.
Cost-effectiveness analysis of integrating screening and treatment of selected non-communicable diseases into HIV/AIDS treatment in Uganda
Sando D, Kintu A, Okello S, Kawungezi P, Guwatudde D, Mutungi G, et al.
J Int AIDS Soc . 2020 Jun; 23 Suppl 1:e25507. PMID: 32562364
Introduction: Despite growing enthusiasm for integrating treatment of non-communicable diseases (NCDs) into human immunodeficiency virus (HIV) care and treatment services in sub-Saharan Africa, there is little evidence on the potential...
10.
A comparison of all-cause and cause-specific mortality by household socioeconomic status across seven INDEPTH network health and demographic surveillance systems in sub-Saharan Africa
Coates M, Kamanda M, Kintu A, Arikpo I, Chauque A, Mengesha M, et al.
Glob Health Action . 2019 May; 12(1):1608013. PMID: 31092155
Background: Understanding socioeconomic disparities in all-cause and cause-specific mortality can help inform prevention and treatment strategies. Objectives: To quantify cause-specific mortality rates by socioeconomic status across seven health and demographic...